MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

53.48 -0.04 (-0.07%)
Streaming Delayed Price Updated: 1:57 PM EST, Feb 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 478,768
Open 52.01
Bid (Size) 53.45 (100)
Ask (Size) 53.59 (300)
Prev. Close 53.52
Today's Range 52.00 - 53.64
52wk Range 30.04 - 78.48
Shares Outstanding 78,935,098
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
CRISPR Therapeutics Gains After Earnings as Pipeline Hope Grows ↗
Via MarketBeat
News headline image
Should You Buy Shares of CRISPR Therapeutics in February? ↗
The company could finally be ready to deliver on years of promise. 
Via The Motley Fool

Performance

YTD
-0.5%
-0.5%
1 Month
+1.7%
+1.7%
3 Month
+5.4%
+5.4%
6 Month
+0.8%
+0.8%
1 Year
+2.4%
+2.4%

More News

Read More
News headline image
The Blastoff-Ready Biotech Stock You'll Kick Yourself for Not Buying in 2026 ↗
Via The Motley Fool
News headline image
Why CRISPR Therapeutics Stock Is Up Today (Despite Its Q4 Earnings Miss) ↗
Via The Motley Fool
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Forget AI Stocks: This Biotech Could Cure What AI Can't Touch ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Nasdaq, S&P 500 Futures Climb Ahead Of Apple Earnings: Why META, TSLA, MP, CRML, SER Are On Traders' Radar Today ↗
Via Stocktwits
Topics Artificial Intelligence ETFs Government
News headline image
Cathie Wood's Favorite Biotech Stock Is Under Pressure Amid Insider Sales And Slow Revenue Growth: Momentum Score Drops ↗
Via Benzinga
News headline image
2 Biotech Stocks That Could Soar This Year ↗
Via The Motley Fool
News headline image
Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
These 2 Healthcare Stocks Beat the Market in 2025. Should You Buy Them in 2026? ↗
Via The Motley Fool
News headline image
The $1.7 Billion Pivot: Agios Pharmaceuticals (AGIO) and the New Frontier of Oral Thalassemia Therapy
Via PredictStreet
Topics Economy
News headline image
Is CRISPR Therapeutics Stock Yesterday's News? ↗
Via The Motley Fool
News headline image
3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term ↗
Via The Motley Fool
News headline image
Is CRISPR Therapeutics a Buy, Sell, or Hold in 2026? ↗
Via The Motley Fool
News headline image
2 Growth Stocks to Invest $1,000 in Right Now ↗
Via The Motley Fool
News headline image
From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes
From USA News Group
Via GlobeNewswire
News headline image
2 Monster Stocks in the Making to Buy and Hold ↗
Via The Motley Fool
News headline image
12 Days of Investing: My Top 12 Stocks to Buy Before 2026 ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
2 Healthcare Stocks to Buy Ahead of the New Year ↗
Via The Motley Fool
News headline image
2 Stocks That Could Soar by 52% and 282%, According to Wall Street ↗
Via The Motley Fool
News headline image
Meet the Beaten-Down Biotech Stock Cathie Wood Loves That Wall Street Says May Soar 50% ↗
Via The Motley Fool
Topics ETFs
News headline image
The Best Stocks to Buy With $1,000 Right Now ↗
Via The Motley Fool
Topics Artificial Intelligence Energy
News headline image
3 Mid-Cap Growth Stocks That Have Mammoth Long-Term Potential ↗
Via The Motley Fool
News headline image
Agios Pharmaceuticals Plunges Over 50% as Sickle Cell Drug Delivers Mixed Phase 3 Results
Via MarketMinute

Frequently Asked Questions

Is CRISPR Therapeutics AG - Common Shares publicly traded?
Yes, CRISPR Therapeutics AG - Common Shares is publicly traded.
What exchange does CRISPR Therapeutics AG - Common Shares trade on?
CRISPR Therapeutics AG - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for CRISPR Therapeutics AG - Common Shares?
The ticker symbol for CRISPR Therapeutics AG - Common Shares is CRSP on the Nasdaq Stock Market
What is the current price of CRISPR Therapeutics AG - Common Shares?
The current price of CRISPR Therapeutics AG - Common Shares is 53.48
When was CRISPR Therapeutics AG - Common Shares last traded?
The last trade of CRISPR Therapeutics AG - Common Shares was at 02/19/26 01:57 PM ET
What is the market capitalization of CRISPR Therapeutics AG - Common Shares?
The market capitalization of CRISPR Therapeutics AG - Common Shares is 4.22B
How many shares of CRISPR Therapeutics AG - Common Shares are outstanding?
CRISPR Therapeutics AG - Common Shares has 4B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story